Learn More About Our Dermatology Expertise
For your convenience, our brochures and case studies can be accessed here.
The evolution of biologics within the dermatology landscape Biologics present new treatment options for dermatology patients who haven’t seen positive results from traditional treatment methods, such as topicals, phototherapy or traditional drugs. This paper explores the evolution of biologics within … Read More
Our Dermatology Division is led by a team of specialists with 20+ years of experience spanning dermatology products and aesthetics. Download our brochure to learn more about our full range of global dermatology CRO services.
The difference between successful clinical trial enrollment and missed deadlines is comprehensive patient recruitment management planning. Download this overview to learn which of our three management plans can help you meet patient recruitment goals.
We offer a comprehensive range of regulatory services for dermatology sponsors of all sizes. Before your next dermatology trial, talk to us about regulatory strategies to help save time and avoid frustrating obstacles.
Our data management and biostatistics teams use leading technologies that provide access to clinical trial data as well as status information throughout the trial. Learn more about our data management, biostatistics and medical writing services.
After a delayed last patient in (LPI) date, Novella Clinical reviewed the tactics and helped devise and execute a campaign that helped sites complete enrollment for a Phase I and IIa acne vulgaris study in Canada.
Patient recruitment services fulfilled (4) Phase III actinic keratosis (AK) enrollment goals up to 75% faster than sponsor-projected timelines and significantly reduced overall study spending.
Numerous site and data/quality monitoring solutions led to sooner-than-anticipated project completion within outlined budgets on a Global Phase II study in atopic dermatitis.
This Phase II atopic dermatitis recruitment program delivered accelerated enrollment in US study, and reduced the patient recruitment timeline by 25 weeks.
Novella Clinical increased the enrollment rate and beat projected timelines by five weeks in a Phase II common warts study
Unique predictive enrollment model reduced projected enrollment period from 52 to 30 weeks in a Phase III multi-center external genital warts study.
Novella Clinical’s strategic training approach dramatically reduced screen failure rates in a Phase II hyperhidrosis study US and Germany.
Successful patient recruitment strategies in 13 countries where some are unfamiliar with advertising to support enrollment on four Phase II psoriasis studies.
Patient recruitment in Phase II onychomycosis study delivers accelerated enrollment, reducing patient recruitment management timelines by 35%.
Novella Clinical’s strategic patient recruitment process reduced enrollment timelines for two Phase II psoriasis studies, and enrolled 700 patients ahead of schedule.
Novella Clinical’s patient recruitment process and predictive enrollment expertise dramatically reduces enrollment timelines for Phase III multi-center psoriasis study.